Generative AI Based Puncture Surgery Navigation System
Combination ProductParticipants will receive percutaneous lung puncture under the guidance of GPS.
NCT Number: NCT06762613
The goal of this clinical trial is to learn if Generative AI Based Puncture Surgery Navigation System (GPS) can guide lung puncture in adults better. It will also learn about the quality improvement of cone beam CT (CBCT) by GPS. The main questions it aims to answer are:
* Does GPS lower the number of punctures, radiation dose, and complications of participants undergo percutaneous lung puncture? * Does GPS improve the quality of CBCT images? Researchers will compare GPS to a conventional CBCT guided percutaneous lung puncture to see if GPS can improve the efficacy of lung puncture.
Participants will:
* Take the percutaneous lung puncture by the guidance of GPS or conventional CBCT (placebo) * The number of punctures, the success rate of the procedure, the radiation dose, intraoperative complications and postoperative complications at 7 days will be recorded * The images of CBCT will be collected
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Wuhan Union Hospital, Wuhan, Hubei, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive percutaneous lung puncture under the guidance of GPS.
Participants will receive percutaneous lung puncture under the guidance of cone beam CT.
Time frame: From enrollment to the end of the lung puncture procedure.
The number of punctures was defined as the number of punctures performed throughout the percutaneous lung puncture procedure.
Time frame: From enrollment to the end of the lung puncture procedure.
Radiation dose was defined as the radiation dose generated throughout the percutaneous lung puncture procedure.
Time frame: From enrollment to the end of the lung puncture procedure.
Puncture time was defined as the duration of the entire percutaneous lung puncture procedure.
Time frame: From enrollment to the end of the lung puncture procedure at 1 week.
Intraoperative and postoperative complications were defined as those arising in parricipants during percutaneous lung puncture and within 7 days after puncture.
Time frame: Through study completion, an average of three months.
peak signal-to-noise ratio (PSNR) is a metric used to measure the quality of an image or video, assessing the degree of distortion by comparing the peak signal power to the mean square error (MSE) between the original signal and the compressed or processed signal. PSNR is measured in decibels (dB), with higher values indicating less distortion and better image or video quality.
Time frame: Through study completion, an average of 3 months.
Structural similarity (SSIM) is a metric for evaluating the similarity of two images. SSIM value is between 0 and 1, the larger the value, the more similar the images are.
Time frame: Through study completion, an average of 3 months.
Doctors' scoring of image and lesion quality were got based on the 5-point scale Likert (1-5 points). Rated 5 out of 5 for very good images, 4 out of 5 for good, 3 out of 5 for moderate, 2 out of 5 for poor, 1 out of 5 for very poor.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Other
Enhancing CBCT-Guided Lung Nodule Puncture Efficiency With Generative AI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07300072
Lung Nodules, Pleural Diseases
Taichung, Taiwan
View Trial DetailsNCT07035977
Lung Nodules
Zhengzhou, Henan, China
View Trial DetailsNCT07055997
Disease, Lung Cancer (Diagnosis)
Guangzhou, Guangdong, China
View Trial DetailsNCT00613041
Lung Nodules, Undiagnosed Pulmonary Nodules
New York, United States
View Trial Details